Alnylam Pharmaceuticals Inc (ALNY)

117.74 -2.87  -2.38% NASDAQ Dec 13, 20:00 Delayed 2m USD

Alnylam Pharmaceuticals Debt to Equity Ratio (Quarterly):

0.00 for Sept. 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Debt to Equity Ratio (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Debt to Equity Ratio (Quarterly) Data

View and export this data going back to 2003. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2019 0.00
June 30, 2019 0.0171
March 31, 2019 0.0194
Dec. 31, 2018 0.023
Sept. 30, 2018 0.0203
June 30, 2018 0.0185
March 31, 2018 0.0171
Dec. 31, 2017 0.017
Sept. 30, 2017 0.1417
June 30, 2017 0.1336
March 31, 2017 0.1805
Dec. 31, 2016 0.163
Sept. 30, 2016 0.1478
June 30, 2016 0.1366
March 31, 2016 0.00
Dec. 31, 2015 0.00
Sept. 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
Dec. 31, 2014 0.00
Sept. 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
Dec. 31, 2013 0.00
Sept. 30, 2013 0.00
   
June 30, 2013 0.00
March 31, 2013 0.00
Dec. 31, 2012 0.00
Sept. 30, 2012 0.00
June 30, 2012 0.00
March 31, 2012 0.00
Dec. 31, 2011 0.00
Sept. 30, 2011 0.00
June 30, 2011 0.00
March 31, 2011 0.00
Dec. 31, 2010 0.00
Sept. 30, 2010 0.00
June 30, 2010 0.00
March 31, 2010 0.00
Dec. 31, 2009 0.00
Sept. 30, 2009 0.00
June 30, 2009 0.00
March 31, 2009 0.00
Dec. 31, 2008 0.00
Sept. 30, 2008 0.0193
June 30, 2008 0.0246
March 31, 2008 0.0288
Dec. 31, 2007 0.0339
Sept. 30, 2007 0.0397
June 30, 2007 0.0475

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Debt to Equity Ratio

Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.

A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.

It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More

Advertisement

Debt to Equity Ratio (Quarterly) Benchmarks

Benchmarks
The Medicines Co --
Regeneron Pharmaceuticals Inc 0.00
Amgen Inc 2.726

Debt to Equity Ratio (Quarterly) Range, Past 5 Years

Minimum 0.00 Dec 2014
Maximum 0.1805 Mar 2017
Average 0.0518
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.